A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.

Artificial intelligence has entered a new phase inside health systems. For the past several years, AI initiatives largely lived in innovation centers, small pilots and controlled vendor tests. Today, ...

Chronic hypoxia improves glucose tolerance in mice through insulin-independent mechanisms, with red blood cells acting as a major systemic glucose sink. Increased erythrocyte production and altered ...

The use of the PREVENT (predicting risk of cardiovascular disease events) risk calculator, which combines measures of cardiovascular, kidney, and metabolic health to estimate cardiovascular disease ...

Yasmin Mowat recieves funding from a National Health and Medical Research Council (NHMRC) Partnership Grant, implemented with Lifeblood. David Irving works for Australian Red Cross Lifeblood and is ...

Beyond the myriad complications that come with diabetes, patients have to additionally put up with regular blood sugar testing – which involves either multiple pin pricks a day to draw blood or ...

Ever wondered how the Earth and Moon interact? In this video, we’ll simulate their system using Python, showcasing orbits, gravity, and motion. Perfect for aspiring coders and space enthusiasts!

NEWPORT NEWS, Va. — The U.S. Army has taken a significant step to modernize how it manages Soldiers’ training data. On Nov. 15, ATIS Training — a streamlined, intuitive platform for managing ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

Oct 10 (Reuters) - The New York state court system on Friday set out a new policy on the use of artificial intelligence by judges and other court staff, joining at least four other U.S. states that ...

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm ...